James L. Slack

Decitabine improves patient outcomes in myelodysplastic syndromes

Hagop M. Kantarjian, Jean‐Pierre J. Issa, C Rosenfeld et al. · Cancer · 2006 · 1.5K citations

Medicine, Hematology, Pharmacology +14

Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML

Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Multicenter Study of Decitabine Administered Daily for 5 Days Every 4 Weeks to Adults With Myelodysplastic Syndromes: The Alternative Dosing for Outpatient Treatment (ADOPT) Trial

David P. Steensma, Maria R. Baer, James L. Slack et al. · Journal of Clinical Oncology · 2009 · 314 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Advances in second generation high temperature superconducting wire manufacturing and R&amp;D at American Superconductor Corporation

M.W. Rupich, Xiaoping Li, Cees Thieme et al. · Superconductor Science and Technology · 2009 · 167 citations

Natural Sciences, Materials Engineering, Materials Science +13

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502

Steven M. Devine, Kouros Owzar, William Blum et al. · Journal of Clinical Oncology · 2015 · 163 citations

Medicine, Geriatric Medicine, Hematology +17